The U.S. government continues to end contracts related to the $5 billion Project NextGen initiative, this time terminating ...

The U.S. Centers for Disease Control and Prevention’s outside panel of vaccine experts on Tuesday discussed narrowing ...

Shares of Moderna ( MRNA 6.82%) are falling on Monday. The company's stock lost 7.9% as of 1:30 p.m. ET and was down as much as 13.9% earlier in the day. The steep decline comes as the S&P 500 and ...

However, in the later stages of the pandemic, demand for the product declined, and Moderna shifted to a loss. For example, last year, the company brought in $3.2 billion in revenue, compared to more ...

Vaccine stocks are down after the health agency's top immunization official announced the move Monday, citing Secretary ...

Shares of some U.S. biotechnology companies including Moderna (MRNA) plunged on Monday after reports that the top vaccine official at the U.S.

Moderna (MRNA) and other vaccine maker stocks ... that Marks resigned after an official at the Department of Health and Human Services (HHS) told him he could either quit or be fired.

Moderna Inc MRNA -11.5% Get Free Report shares were down 13.5% at $26.88 and Novavax Inc NVAX -9.02% Get Free Report shares were down 9.6% at $6.30 at last check. The SPDR S&P Biotech ETF XBI -4.88% + ...

Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary ...

Moderna was awarded $590 million by the U.S. Department of Health and Human Services (HHS) in January to continue developing a vaccine to protect against bird flu. The Trump administration was ...

Moderna (NASDAQ: MRNA ... His resignation letter suggested he and new Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. weren't in agreement on the path forward.